No abstract available.
Constriction, Pathologic

No abstract available.
Carcinoma, Hepatocellular* ; Recurrence*

PURPOSE: This study was done to identify that Rooming-in of new mothers have an influence on continuous breast feeding. METHOD: This is a comparative survey study which was done by self reported questionnaire and telephone contacts. The subjects are collected from two groups which consist of 29 in Rooming-in group and 24 in Non-Rooming-in group respectively. The data were collected method of this study was lists of given to mothers while they were in the hospital and interviews by telephone were done at their home 3 months and 6 months after delivery. RESULT: The results of this study were as follows: 1. The rates of breast feeding were 79.3% in the Rooming-in group and 41.7% in the non-Rooming-in group after 3 months. There was a statistically significant difference between the two groups(chi2=10.217, p=.009). 2. The rates of breast feeding were 69.0% in the Rooming-in group and 29.2% in the Non-Rooming-in group at 6 months. There was a statistically significant difference between the two groups(chi-square=10.310, p=.012). CONCLUSION: Rooming-in system provoke an increase of the breast feeding rate in new mothers and encourage them to keep breast feeding. In addition, it would be desirable that hospitals apply Rooming-in system actively and encourage new mothers to breast feed for 24 hours a day. It could be make breast feeding successful.
Breast ; Breast Feeding ; Humans ; Mothers ; Surveys and Questionnaires ; Self Report ; Telephone

No abstract available.
Hepatic Veins*

No abstract available.
Carcinoma, Hepatocellular*

No abstract available.
Breast Neoplasms* ; Breast*

Due to recent rapid advances in imaging modalities, there has been a marked increase in the early diagnosis of hepatocellular carcinoma (HCC). Also, the emergence of effective local treatment methods has lead to the necessity for a wider selection of therapeutic modalities depending on the individual characteristics of each patient, such as tumor factors and hepatic factors, rather than a single uniform approach. At present, accurate preoperative liver function evaluation is available, and in addition, increased knowledge of the liver anatomy through liver transplantation, and advances in postoperative patient care has subsequently decreased the morbidity and mortality rates significantly after surgery. Such newly developed techniques and acquired knowledge has allowed the surgical option to expand from the classical hepatic lobectomy to systematic subsegmentectomy. Not only for early HCC, but also for intermediate HCC and advanced HCC, hepatectomy has shown the best results in each stage of disease with regard to treatment goals. It is therefore thought that hepatectomy should always be considered as the main treatment method in the multimodality treatment of HCC, as long as the liver function reserve permits, to enhance the quality of life, increase survival, and to cure disease. The authors present here a summary of the role of surgical approaches in HCC with respect to recent increases in the detection of early stage disease, new therapeutic modalities, and a new staging system for HCC.
Carcinoma, Hepatocellular/*surgery ; English Abstract ; Hepatectomy/methods ; Humans ; Liver Neoplasms/*surgery

No abstract available.
Liver Transplantation* ; Liver*

The effects of KCI continus tablet(K-Contin(R)) on the serum level of K and uric acid during hydrochlorothizide therapy(25mg/day) were evaluated in 30 patients with essential hypertensien. The results are as follows : 1) During hydrochlorothiazide therapy(25mg/day), 23% of all patients showed hypopotassemia(<3.5mEq/1) while no patient developed hypopotassemia after potassium supplement therapy(8 mEq/day). 2) During the period of K supplement, the level of serum uric acid showed less elevation. 3) The side reaction of KCI continus tablet were mild indigestion which developed in two patients and disappeared soon without any particular treatment. In conclusion, the KCI continus tablet is useful in the prevention of hypopotassemia during chronic diuretic therapy.
Dyspepsia ; Humans ; Hydrochlorothiazide ; Hypokalemia ; Potassium ; Uric Acid*

No abstract availalbe.
Liver*